PolyNovo Limited (ASX: PNV) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
PolyNovo Limited Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
PolyNovo Limited (ASX: PNV)
Latest News
Healthcare Shares
ASX biotech chair scoops up more stock
Broker Notes
5 ASX 200 shares set to rise by 30% to 45% over the next 12 months: Experts
Share Market News
9 ASX shares including Nuix and PolyNovo dumped from ASX 200
Share Fallers
What do the worst performing stocks on the ASX 200 today all have in common?
Share Market News
These are the 10 most shorted ASX shares
Share Market News
5 things to watch on the ASX 200 on Monday
Share Gainers
Here are the top 10 ASX 200 shares today
Broker Notes
4 ASX All Ords shares set to rise 40% to 50% over the next year: Broker
Share Gainers
Here are the top 10 ASX 200 shares today
Healthcare Shares
Guess which ASX 200 stock is rocketing on big US news
Share Gainers
Why Collins Foods, Invictus Energy, NRW, and Polynovo shares are storming higher
Share Market News
These are the 10 most shorted ASX shares
Frequently Asked Questions
-
The company was formerly known as Calzada Limited and changed its name to PolyNovo Limited in November 2014. PolyNovo Limited was listed on the ASX on 26 November 1998 and is headquartered in Melbourne.
-
No, the company does not historically pay dividends.
PNV ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About PolyNovo Limited
PolyNovo Ltd (ASX: PNV) develops and commercialises innovative medical devices using its patented NovoSorb technology.
NovoSorb is a family of biocompatible polymers that are used in the treatment of burns and surgical wounds. They biodegrade into by-products that can be absorbed and excreted by the body. For example, its NovoSorb BTM (Biodegradable Temporising Matrix) can be used to temporarily close a wound and aid the body in generating new tissue.
PolyNovo’s products are sold across Australia and New Zealand, the United States, the United Kingdom, and Europe.
